Summary: The HearX Group launched a new smartphone and tablet-based otoacoustic emissions device with advanced diagnostic features and integrated data management that is designed to enhance accessibility to hearing care.
Takeaways:
- The HearOAE device provides customizable Transient Evoked OAE and Distortion Product OAE screening and diagnostic capabilities
- The device also seamlessly integrates with HearX Group’s suite of detection and diagnostic tools, such as its mHealth Studio, a patient data-management solution.
- HearOAE is designed to improve access to hearing care in situations where non-responsive testing and early intervention is critical.
The HearX Group introduced its newest smartphone and tablet-based otoacoustic emissions (OAE) device, HearOAE.
An FDA-cleared medical device, HearOAE offers fully customizable Transient Evoked OAE (TEOAE) and Distortion Product OAE (DPOAE) screening and diagnostic capabilities. The device also provides integrated data management, making high-quality, affordable hearing testing even more convenient, according to the company.
“Rapid advances in hearing care technology has allowed us to make huge strides in how we detect, diagnose and treat hearing,” says Nic Klopper, HearX Group CEO. “Drawing from cutting-edge audiological science and mobile technology, the HearOAE is a powerful tool in the effort to address worldwide hearing loss.”
The HearOAE is designed to improve access to hearing care in areas where it is most needed, including newborn care, elder care, and in other situations where non-responsive testing and early intervention is critical, for only half the price of traditional OAE devices.
It also integrates with HearX Group’s other detection and diagnostic products, including the popular mHealth Studio, designed to meet today’s healthcare demands with modern digital health tools.
The company officially opened presales for the device after the technology was previewed at the AAA+HearTECH expo in Atlanta in April. The HearOAE is available for pre-order in the U.S. and South Africa now.
